Rex Patrick (SA, Independent) Share this | Hansard source

I might come back to that. It was reported in PharmaDispatch on 10 November 2021 that catch-up price reductions will contribute to something like $1.9 billion in savings in the course of five years because of the agreement between Medicines Australia and the federal government. In terms of calculating that saving—and I'm happy for you to present a different number if that's not correct—I'm wondering which of the brands listed on the PBS are subject to the cuts, because that clearly must have been included as part of the calculation.